COMMUNITY COLLEGE OF ALLEGHENEY COUNTY ALLEGHENY CAMPUS DEPARTMENT OF NURSING NRN 101 AND NRN102 DRUG CARD Directions:

Complete one drug card for each medication Write the rationale for why this patient is getting the prescribed medication. Drug Trade Name: Prinivil, Zestril Physiological Action: Common Side Effects: Fatigue, (How drug works in the body) weakness and fainting. Low blood Generic Name: Lisinopril pressure. Headache, dizziness, ACE inhibitors block the tingling and decreased sexual activity conversion of angiotensin I to the Classification: Antihypertensives vasoconstrictor angiotensin II. Adverse Side Effects: Lisinopril causes the kidneys to retain Usual Ranges: up to 80 mg/day if potassium, which may lead to needed hyperkalemia. * may happen more on older male users. Adult: Pediatric Na Contraindications with food or other Recommended Frequency of drugs: Hypersensitivity. Administration: PO- HTN- Initial: Uses: (Therapeutic) 5-10 mg/day at bedtime. This medication is an angiotensin Maintenance: 20 mg once daily, up converting enzyme (ACE) inhibitor, to 80 mg/day if needed. prescribed for high blood pressure. Heart failure as adjunct: Initial: 2.5 mg/day. Maintenance: 5-40 mg/day as a single dose Recommended Route of Administration: PO Pregnancy Category: C (1st trimester) / D (2nd and 3rd trimester) NURSING CONSIDERATIONS(Before, during or after administration) * Caution should be exercised in patients with history of heart, kidney disease, diabetes, lupus, skin disease, severe allergic reactions with difficulty in swallowing or breathing and painful swelling of the face, throat, tongue, lips, eyes, hands, feet, ankles, or lower legs. * It may cause dizziness, lightheadedness or fainting, do not drive or operate machinery while taking this medication. * It may cause serious side effect called angioedema, if it so consult with your doctor. * Monitor blood pressure, blood sugar, blood electrolyte levels, heart, kidney or liver function regularly while taking this medication. RATIONALE for this Patient: (Why prescribed for patient)

PRESCRIBED Dosage Route

Frequency

Times Given

RT Reviewed 1985/LAB Reviewed June 1989/LAB Reviewed June 1990/KAC Revised July 1991/HPO Revised May 2002/LAC Revised January 2003